| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
Primary endpoint(s) modified |
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
Trial arms changed: 4 -> 5 |
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
date change Primary completion pushed: 2026-08-28 -> 2031-09-23 |
| 2026-06-09 | NCT05627362 A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… |
date change Completion pushed: 2026-08-28 -> 2031-09-23 |
| 2026-06-02 | NCT05361434 A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line… |
Trial completed |
| 2026-06-02 | NCT05361434 A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line… |
date change Completion moved earlier: 2026-11-30 -> 2025-10-20 |
| 2026-06-02 | NCT06016842 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis |
Trial sites expanded: 180 -> 183 locations |
| 2026-06-02 | NCT07314164 Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already… |
Trial sites expanded: 28 -> 34 locations |
| 2026-05-29 | NCT06447168 A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… |
Trial sites expanded: 65 -> 68 locations |
| 2026-05-23 | NCT04821089 A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate… |
Primary endpoint(s) modified |
| 2026-05-21 | NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-21 | NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours |
Enrollment reduced: 220 -> 36 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07623187 A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With… | Phase 2/3 | Not Yet Recruiting |
| 2026-05-15 | NCT07588880 A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With… | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07427797 | A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to… | Moderate to Severe Glabellar Lines | Recruiting |
| NCT07435428 | A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With… | Moderate to Severe Glabellar Lines | Recruiting |
| NCT07387549 | A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With… | Primary Sclerosing Cholangitis | Recruiting |
| NCT06016842 | A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis | Primary Biliary Cholangitis (PBC) | Recruiting |
| NCT06047444 | A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of… | Chronic Migraine | Active, Not Recruiting |
| NCT06047457 | A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of… | Episodic Migraine | Active, Not Recruiting |
| NCT06383403 | A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response… | Primary Biliary Cholangitis | Active, Not Recruiting |
| NCT06730061 | A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis… | Primary Biliary Cholangitis | Active, Not Recruiting |
| NCT04526665 | Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) | Primary Biliary Cirrhosis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07623187 | A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With… | Acute Myeloid Leukaemia (AML) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06625060 | A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic… | Episodic Migraine | Recruiting |
| NCT06937931 | A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults | Cervical Dystonia | Recruiting |
| NCT05627362 | A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… | Primary Sclerosing Cholangitis | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04752774 | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper… | Spasticity | Recruiting |
| NCT06833008 | A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With… | Advanced Solid Tumor | Recruiting |
| NCT07213817 | A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic… | Locally Advanced Solid Tumor | Recruiting |
| NCT07213830 | A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics… | Advanced Solid Tumor | Recruiting |
| NCT06305247 | A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours | Melanoma | Active, Not Recruiting |
| NCT04821089 | A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate… | Moderate to Severe Upper Facial Lines | Active, Not Recruiting |
| Phase 1 | |||
| NCT07441707 | A Study to Assess a Medicine Called Tovorafenib in Japanese Children and Young Adults… | Low-grade Glioma | Recruiting |
| Not specified | |||
| NCT07588880 | A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With… | Progressive Familial Intrahepatic Cholestasis | Recruiting |
| NCT06089616 | A Study to Document and to Further Describe Long-term Safety and Effectiveness of… | Fibrodysplasia Ossificans Progressiva | Recruiting |
| NCT06258902 | Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety… | Pregnancy Related | Recruiting |
| NCT06447168 | A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… | Primary Biliary Cholangitis | Recruiting |
| NCT06850038 | A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in… | Alagille Syndrome | Recruiting |